-
-
$BNTX Good price action with offering - could set up a short squeeze back over 40$ soon$NTGN could be over 2$https://twitter.com/gcbioinv/status/1224448176989466624 … -
#BioNTech Announces Commencement of#PublicOffering of American Depositary Shares$BNTX https://www.1stoncology.com/blog/biontech-announces-commencement-of-public-offering-of-american-depositary-shares1234553769 … -
$BNTX just bounced off the 0.618 extension, wave C is complete and we are starting to move into wave 3 pic.twitter.com/tkdhFMB5v5
Prikaži ovu nit -
$WOGI This one getting ready to make a move out of trips. Call the company they are excited for what's ahead $$$AGTC$MNPR$PRTA$CRTX$CABA$MWK$RAD$SYRS$ABUS$RUHN$BNTX$ADBE$FCEL$XENE$SMLR$CRM$ORCL$MSFT$SAVA$SIRI$INPX$KRTX$MREO$DBVT$GPRO$YNDX$MU$JD$MBOTpic.twitter.com/avuwxGEgvF
-
$BNTX offers 6m ADR shares in secondary offering -
-
$NTGN Trading at a steep discount to$BNTX buyout price - a steal below $1.6 Traders not doing the math here pic.twitter.com/dIh78MxQTb -
$NTGN Essentially free money
at this point
$BNTX pic.twitter.com/kHjEoZ9XhG -
BioNTech SE Provides Update on Corporate Progress and Third Quarter 2019 Financial Results
$BNTX https://newsfilter.io/articles/biontech-se-provides-update-on-corporate-progress-and-third-quarter-2019-financial-results-42ea154db0cb897293fb79ff1d80e690 … -
Prikaži ovu nit
-
$VERB: NEVER BE DISMISSIVE----DISRUPTIVE TECH...HERE!
NOT MANY SAW $AAPL$NFLX OR$AZMN COMING EITHER$AGTC$MNPR$PRTA$CRTX$CABA$MWK$RAD$SYRS$ABUS$RUHN$BNTX$ADBE$FCEL$XENE$SMLR$CRM$ORCL$MSFT$SAVA$SIRI$INPX$KRTX$MREO$DBVT$GPRO$YNDX$MU$JD$MBOTpic.twitter.com/xwFnKXxoaxVERB THE ULTIMATE BOTTOM PLAY--SEVERELY UNDERVALUED♥ Patent pending Zoom killer platform ♥Big Tech Partners & a Backlog of Clients To On-board ♥Analyst Reports 100's of % Above Current Market ♥Ran over 1000% TWICE From This Level Before -
Some observations (
#biopick2020):
average gain: 18%
contestants in positive: 64%
biggest jump: $nk +141 places
biggest drop: $bntx -96 places
another good week for bios, no JPM sell-off in sight. pic.twitter.com/WPogbjeeYkPrikaži ovu nit -
Biotech updates 01/16:
$DRRX AdCom split vote$NTGN acquired by$BNTX +38% (-89% since Jun'18 IPO)$TCON partner ODD +47%$HTBX offering -24%$TTNP r/split cancelled +14% AH Pipeline updates$FBIO$TGTX$TYMEhttps://www.biopharmcatalyst.com/news/2020/fda-advisory-committee-delivers-split-vote-for-durect-drrx-neon-ntgn-acquired-by-biontech-bntx-38 … -
-
$NTGN restructures and falls to$BNTX in a distressed asset sale. Via@Vantageanalysishttp://bit.ly/36XsMJ2Prikaži ovu nit -
In
#biotech M&A today,$BNTX acquires neoantigen-#cancer-vaccine company$NTGN for $67M. This was Neon's latest:https://www.statnews.com/2019/07/15/cancer-vaccine-checkpoint-inhibitors-immunotherapy/ …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
